Storage and Shipment. 8.1 External Manufacturer specifically waives any and all liens and/or security interests in any of the Product and any Materials which it might acquire by operation of law, by judicial process, by judgment or otherwise.
8.2 External Manufacturer agrees to load and ship the Product, FOB Dock External Manufacturer’s plant (unless otherwise set forth in each Project Agreement), on such carriers, to such destinations, and in such quantities as may be designated by Kraft. For all shipments, External Manufacturer shall comply with shipper load and count procedures, if any, shown in attachments to each Project Agreement.
8.3 All Product supplied by External Manufacturer to Ralcorp hereunder will be free of any and all liens and encumbrances of any kind. For all freight claims, External Manufacturer shall contact the appropriate Ralcorp representative.
Storage and Shipment. Fresenius will store the PRODUCTS under cGMP conditions with appropriate temperature control, and ensure that appropriate controls are in place to prevent interference, theft, product contamination and mixture with any other products or materials. Fresenius will be responsible for affixing all labels, container sealing and integrity, storage and shipping conditions for the PRODUCTS. Fresenius will maintain proper segregation of the PRODUCTS. TransMedics shall be permitted to review Fresenius’s segregation system. Different lots of single PRODUCT or different types of products will not be mixed on a pallet. Fresenius will suitably pack the PRODUCTS in appropriate shippers for transit. Fresenius will ensure that during packaging, storage and shipment of the PRODUCT there is no possibility of deterioration, contamination or admixture with any other materials. Protocols for testing of packaging components shall be mutually agreed upon by the Parties. Fresenius will only deliver PRODUCTS FCA to TransMedics carrier, or as otherwise agreed to by the parties in writing. Only approved, finished PRODUCTS will be shipped by Fresenius to TransMedics, except as otherwise provided. Fresenius will not ship any PRODUCT that is unapproved or under quarantine, unless mutually agreed by the parties.
Storage and Shipment. 7.1 Co-Packer agrees to load and ship the Product, F.O.B. Dock, Co-Packer’s plant in Osceola, Arkansas, on such carriers, to such destinations, and in such quantities as may be designated by the Company. The xxxx of lading should include Product description, Product number, and release order number.
7.2 All Product supplied by Co-Packer to the Company hereunder shall be free of any and all liens, claims, and encumbrances of any kind, other than in favor of Co-Packer, until payment for the Product is received by Co-Packer.
7.3 From time to time, upon each receipt of a written request from the Company, Co-Packer will store the Product in such amounts, for such periods of time and for such storage charges as are mutually agreed-to by the parties, which storage charges shall commence accruing from the thirtieth (30th) day of storage of any Product for the Company; provided, however, after any product has been stored for thirty (30) days, Co-Packer shall invoice the Company for the purchase price of any such Product, and the Company shall pay such purchase price in accordance with the terms of section 6 hereof. Notwithstanding anything to the contrary herein, to the extent that the Company does not take delivery of any Product which has been stored for in excess of six (6) months, Co-Packer shall have no responsibility whatsoever as to whether such Product is fit for human consumption, and the Company shall indemnify, hold harmless, and defend Co-Packer from any and all liabilities arising from the use of any such Product. The foregoing is subject to Co-Packer having sufficient warehouse space to store the Product.
Storage and Shipment. 5.6.1 CATALENT will store the bulk PRODUCT under conditions specified by PRODUCT label requirements as supplied by INTERMUNE. CATALENT will ensure that during storage before shipping of the PRODUCT, appropriate controls are in place to insure that there is no interference, theft, contamination, or mixture with any other products or materials. INTERMUNE will provide details of any labeling requirements, container sealing and integrity, and storage and shipping conditions for the PRODUCT.
5.6.2 The PRODUCT will be labeled and packaged according to instructions provided to CATALENT in writing by INTERMUNE and complying with CGMP.
5.6.3 CATALENT will maintain proper segregation of the PRODUCT according to established CATALENT systems and procedures. Different types of products will not be mixed on a single pallet.
5.6.4 Only PRODUCT that has completed FINAL RELEASE will be shipped by CATALENT to INTERMUNE-designated locations approved by INTERMUNE. CATALENT can ship commercial PRODUCT that is under quarantine to other Catalent sites mentioned in the Scope of this document. Shipment of Clinical Trial Materials (“CTM”) that are under quarantine requires prior written consent from INTERMUNE Quality Assurance.
Storage and Shipment. 5.10.1 Storage - C*P will store the PRODUCTS (Schedule IV controlled substances) under conditions in compliance with applicable DEA regulations and approved by CLIENT. C*P will ensure that during storage before shipping of the PRODUCTS that there is no possibility of deterioration, interference, theft, product contamination, or admixture with any other materials. CLIENT will provide details of any labeling requirements and container sealing and integrity.
Storage and Shipment. 5.10.1 Storage - C*P will store the PRODUCTS under conditions approved by ORPHAN as listed in the specifications. C*P will ensure that during storage before shipping of the PRODUCTS that appropriate controls are in place to ensure no interference, theft, product contamination, or admixture with any other materials. ORPHAN will provide details of any labeling requirements and container sealing and integrity.
Storage and Shipment. (a) Storage. Nastech will store the Product under conditions specified by product label requirements. Nastech will ensure that during storage before shipping of the Product appropriate controls are in place to ensure that there is no interference, theft, product contamination, or mixture with any other products or materials. LICENSEE will provide details of any labeling requirements, container sealing and integrity, and storage and shipping conditions for the Product.
Storage and Shipment. ○ DSM shall label and store Product under conditions specified by product label requirements as supplied by OPTHEA. ○ Ensure that during storage of Product before shipment from DSM’s site, appropriate controls are in place to ensure that there is no interference, theft, contamination, or mixture with any other products or materials. ○ Ship Product to locations nominated in writing by OPTHEA. ○ OPTHEA shall provide details of any container sealing and integrity requirements, and storage and shipping conditions for the Product. ○ The Product shall be labelled and packaged for transit in accordance with instructions and destination as defined by OPTHEA in writing and complying with cGMP and other applicable regulations. ○ A shelf life for Product will not be defined by DSM until sufficient data is available from stability studies to support such storage. ○ DSM shall not ship any Product that is under Quarantine unless in accordance with applicable regulatory guidelines, and then, only according to controlled procedures which fully comply with such regulatory requirements and where such shipment is mutually agreed between the Parties. Attachment 2 to PRC-BRN-00238 Page 55 of 63 ○ In the event that OPTHEA requests DSM to ship Product under Quarantine, DSM shall only ship Product after written approval of OPTHEA. ○ OPTHEA is responsible for ensuring that the third party can accept shipment of Product. Document Retention ○ DSM shall retain, at a minimum, Batch production and test records for Product and materials in accordance with regulatory requirements in the region within which the Product will enter clinical trials. ○ DSM shall notify OPTHEA prior to destruction of any Batch, Product related documentation or materials at the completion of the retention period and, if requested in writing, DSM shall provide such records or materials to OPTHEA. ○ Evaluate DSM by audit according to the allowances outlined above ○ OPTHEA will approve destruction of records of request receipt following the storage period. Regulatory ○ DSM shall be responsible for registering and maintaining DSM’s facilities with the proper regulatory agencies and to update the registration according to the requirements of those agencies. ○ If requested by OPTHEA under the Services, DSM will draft and review the relevant C&MC sections of a regulatory dossier. ○ Following submission of a regulatory data pack dossier by OPTHEA to a regulatory authority, DSM will support update and review of relevant...
Storage and Shipment. RA shall have the primary responsibility to store the Branded Products and to ship the Branded Products to Distributors, retail outlets, and directly to consumers.
Storage and Shipment. 6.11.1 Storage - PYRAMID will store the Product as per the Product Specifications approved by XERIS. PYRAMID will ensure there is no possibility of interference, theft, product contamination, or admixture with any other materials during storage before shipping of the Product. XERIS will provide details of any labeling and container requirements including container sealing and integrity.
